Missing a single dose usually does not undo weight-loss progress because these medications work gradually over time
That's not pathology, it's adaptation
This study found that people taking GLP-1 medications had a higher chance of developing nonscarring hair loss, says Adam Friedman, MD, a study coauthor and chair of the dermatology department at George Washington University in Washington, DC
It is now my great honor to present this to you and I am deeply appreciative of your support
Los iDPP-4 no se han estudiado en nios, los estudio derivan de poblacin adulta, los eventos adversos son escasos46-49, lo que los hace atractivo para jvenes
Still, insurance coverage and cost considerations mean both drugs remain relevant, and patient-centred conversations about therapy choice are critical. GLP-1s beyond weight loss as multi-system therapies Liver disease and metabolic steatohepatitis Non-alcoholic fatty liver disease (NAFLD) and the more severe metabolic dysfunction-associated steatohepatitis (MASH) have few effective pharmacologic treatments